Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Beyond Air, Inc. Common Stock (XAIR)

Surgical & Medical Instruments & Apparatus

https://www.beyondair.net

Beyond Air Inc is a clinical-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.

900 STEWART AVENUE, SUITE 301
GARDEN CITY, NY

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

04/27/2016

Market Cap

21,306,389

Shares Outstanding

31,970,000

Weighted SO

31,972,434

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

LUCD --.--%

NARI --.--%

PAVMZ --.--%

CLPT --.--%

TBIO --.--%

RCEL --.--%

SGHT --.--%

TMCI --.--%

Beta

-0.0990

Last Div

0.0000

Range

0.356-3.348

Chg

0.0830

Avg Vol

830601

Mkt Cap

21306389

Exch

NASDAQ

Country

US

Phone

516 665 8200

DCF Diff

0.6874

DCF

-0.2346

Div Yield

0.0000

P/S

11.9497

EV Multiple

-0.5970

P/FV

1.3033

Div Yield %

0.0000

P/E

-0.3603

PEG

-0.1675

Payout

0.0000

Current Ratio

2.6269

Quick Ratio

2.4235

Cash Ratio

0.3735

DSO

133.8811

DIO

248.9559

Op Cycle

382.8370

DPO

324.2362

CCC

58.6008

Gross Margin

-0.9661

Op Margin

-34.0510

Pretax Margin

-34.9383

Net Margin

-32.7246

Eff Tax Rate

0.0487

ROA

-1.2548

ROE

-2.6601

ROCE

-1.7473

NI/EBT

0.9366

EBT/EBIT

1.0261

EBIT/Rev

-34.0510

Debt Ratio

0.3422

D/E

0.9864

LT Debt/Cap

0.4809

Total Debt/Cap

0.4966

Int Coverage

-33.9179

CF/Debt

-3.0823

Equity Multi

2.8828

Rec Turnover

2.7263

Pay Turnover

1.1257

Inv Turnover

1.4661

FA Turnover

0.1261

Asset Turnover

0.0383

OCF/Share

-1.0685

FCF/Share

-1.2345

Cash/Share

0.4706

OCF/Sales

-27.5059

FCF/OCF

1.1554

CF Coverage

-3.0823

ST Coverage

-50.8218

CapEx Coverage

-6.4336

Div&CapEx Cov

-6.4336

P/BV

1.3033

P/B

1.3033

P/S

11.9497

P/E

-0.3603

P/FCF

-0.3760

P/OCF

-0.4287

P/CF

-0.4287

PEG

-0.1675

P/S

11.9497

EV Multiple

-0.5970

P/FV

1.3033

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Dec 27, 07:30 Beyond Cancerâ„¢ Phase 1 Study Clears Cohort 1 in Patients with Advanced Relapsed or Refractory Unresectable Primary or Metastatic Cutaneous or Subcutaneous Solid Tumors

Revenue Product Segmentation